| The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models ST Durant, L Zheng, Y Wang, K Chen, L Zhang, T Zhang, Z Yang, ... Science advances 4 (6), eaat1719, 2018 | 282 | 2018 |
| Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors J Kahn, A Gillespie, M Tsokos, J Ondos, E Dombi, K Camphausen, ... Frontiers in oncology 4, 324, 2014 | 131 | 2014 |
| The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells J Kahn, TJ Hayman, M Jamal, BH Rath, T Kramp, K Camphausen, ... Neuro-oncology 16 (1), 29-37, 2014 | 103 | 2014 |
| Brachytherapy training survey of radiation oncology residents SR Marcrom, JM Kahn, LE Colbert, CM Freese, KN Doke, JC Yang, ... International Journal of Radiation Oncology* Biology* Physics 103 (3), 557-560, 2019 | 86 | 2019 |
| Preclinical models in radiation oncology J Kahn, PJ Tofilon, K Camphausen Radiation oncology 7, 1-5, 2012 | 84 | 2012 |
| Orally bioavailable and blood–brain barrier-penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice J Karlin, J Allen, SF Ahmad, G Hughes, V Sheridan, R Odedra, ... Molecular cancer therapeutics 17 (8), 1637-1647, 2018 | 67 | 2018 |
| Primary treatment options for high-risk/medically inoperable early stage NSCLC patients GC Jones, JD Kehrer, J Kahn, BN Koneru, R Narayan, TO Thomas, ... Clinical lung cancer 16 (6), 413-430, 2015 | 65 | 2015 |
| Top concerns of radiation oncology trainees in 2019: Job market, board examinations, and residency expansion J Kahn, CR Goodman, A Albert, A Agarwal, E Jeans, K Tye, SR Campbell, ... International journal of radiation oncology, biology, physics 106 (1), 19-25, 2020 | 52 | 2020 |
| Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques J Kahn, JS Loeffler, A Niemierko, EA Chiocca, T Batchelor, A Chakravarti International Journal of Radiation Oncology* Biology* Physics 81 (1), 232-238, 2011 | 48 | 2011 |
| COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation VM Williams, JM Kahn, MM Harkenrider, J Chino, J Chen, LC Fang, ... Brachytherapy 19 (4), 401-411, 2020 | 44 | 2020 |
| A survey study of female radiation oncology residents’ experiences to inform change VW Osborn, K Doke, KA Griffith, R Jones, A Lee, G Maquilan, AH Masters, ... International Journal of Radiation Oncology* Biology* Physics 104 (5), 999-1008, 2019 | 38 | 2019 |
| Increasing medical student engagement through virtual rotations in radiation oncology JM Kahn, EC Fields, E Pollom, L Wairiri, N Vapiwala, N Nabavizadeh, ... Advances in Radiation Oncology 6 (1), 100538, 2021 | 35 | 2021 |
| The case for brachytherapy: why it deserves a renaissance VM Williams, JM Kahn, NG Thaker, S Beriwal, PL Nguyen, D Arthur, ... Advances in radiation oncology 6 (2), 100605, 2021 | 23 | 2021 |
| Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review DC Marshall, ES Tarras, A Ali, J Bloom, MA Torres, JM Kahn CA: a cancer journal for clinicians 72 (4), 353-359, 2022 | 18 | 2022 |
| Radiation oncology virtual education rotation (ROVER) for medical students JM Kahn, N Sandhu, R von Eyben, C Deig, JP Obeid, JA Miller, E Pollom International Journal of Radiation Oncology* Biology* Physics 111 (1), 29-35, 2021 | 18 | 2021 |
| Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation J Kahn, B Dahman, C McLaughlin, P Kapoor, R Kapoor, E Harris, ... Brachytherapy 19 (2), 228-233, 2020 | 16 | 2020 |
| Competitive but not allosteric mTOR kinase inhibition enhances tumor cell radiosensitivity TJ Hayman, T Kramp, J Kahn, M Jamal, K Camphausen, PJ Tofilon Translational oncology 6 (3), 355-362, 2013 | 15 | 2013 |
| Where are the women in radiation oncology? A cross-sectional multi-specialty comparative analysis B Odei, J Kahn, EB Holliday, DA Diaz, E Bello-Pardo, J Odei, J Bae, ... Advances in radiation oncology 6 (5), 100735, 2021 | 14 | 2021 |
| The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv. 2018; 4 (6): eaat1719 ST Durant, L Zheng, Y Wang, K Chen, L Zhang, T Zhang, Z Yang, ... Article PubMed PubMed Central CAS, 2022 | 13 | 2022 |
| Implications of medical board certification practices on family planning and professional trajectory for early career female radiation oncologists LL Dover, C Hentz, JM Kahn, A Lee, A Masters, K Doke, CR Goodman Practical radiation oncology 12 (2), 95-102, 2022 | 9 | 2022 |
